| Date | Form | Description | Docs | XBRL | Pages |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 8-K | Current report filing |
|
25 | |
| 07/20/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/02/20 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/02/20 | 8-K | Current report filing |
|
6 | |
| 06/22/20 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
46 | |
| 06/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Read More...Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
Read More...